This new 'off-the-shelf' vaccine, ELI-002 2P, is making waves for people battling pancreatic and colorectal cancers. In a recent trial, 84% of patients developed cancer-fighting T cells, and some even saw their tumors completely cleared! What’s wild is that this vaccine doesn’t need to be custom-made for each person, making it way more accessible. If these results hold up, we could be looking at a whole new way to fight some of the toughest cancers out there. #Health #BodyHealth #CancerResearch